Katy Jarman

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

I. Judson, B. Seddon, M. Tattersall, 2019, The Lancet. Oncology.

A vision for inclusive and transparent health data in the beyond. Learning

M. Tattersall, I. Judson, B. Seddon, 2019 .